Australia markets closed

NeuroScientific Biopharmaceuticals Limited (NSB.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0360-0.0020 (-5.26%)
At close: 03:00PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Operating expenses
Research development
1,362
4,026
7,220
2,218
1,423
Selling general and administrative
1,436
1,766
2,733
1,575
1,152
Total operating expenses
3,161
6,124
10,504
4,224
2,941
Operating income or loss
-4,320
-6,124
-10,504
-4,224
-2,941
Interest expense
-
4.734
-
0.063
3.417
Total other income/expenses net
40.54
4,953
-
1,018
40.54
Income before tax
761.172
-1,069
-10,435
-3,178
-2,869
Income tax expense
0
0
0
0
0
Income from continuing operations
761.172
-1,069
-10,435
-3,178
-2,869
Net income
761.172
-1,069
-10,435
-3,178
-2,869
Net income available to common shareholders
761.172
-1,069
-10,435
-3,178
-2,869
Basic EPS
-0.05
-0.01
-0.07
-0.02
-0.04
Diluted EPS
-0.05
-0.01
-0.07
-0.02
-0.04
Basic average shares
143,472
143,472
143,472
143,472
78,385
Diluted average shares
143,472
143,472
143,472
143,472
78,385